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Higher vitamin D status, lower adiposity, and longer telomere length are each reportedly associated with lower
risk of several chronic diseases and all-cause mortality. However, direct relationships between vitamin D status
(measured by circulating 25-hydroxyvitamin D (25(OH)D) concentration), adiposity, and telomere length are not
well established. We conducted a cross-sectional analysis of associations of 25(OH)D and body mass index
(BMI; weight (kg)/height (m)2) with mean relative leukocyte telomere length (LTL) using data gathered on 5,096
participants from Northern Finland Birth Cohort 1966 at age 31 years (1997). 25(OH)D was not associated with
LTL in either basic orconfounder/mediator-adjustedmodels. BMIwas inverselyassociatedwith LTLafteradjustment
for potential confounding by age, sex, socioeconomic position, physical activity, diet, smoking, alcohol intake, and
use of oral contraceptives (per 1-unit increase in BMI, mean difference in LTL =−0.4%, 95% confidence interval:
−0.6,−0.2). The BMI-LTL association was also independent of 25(OH)D and was attenuated slightly, but remained,
after adjustment for C-reactive protein, a marker of low-grade inflammation (mean difference in LTL =−0.3%, 95%
confidence interval −0.6, −0.1). These findings suggest that vitamin D status is unlikely to be an important deter-
minant of LTL, at least by young adulthood. Inflammation may partly mediate associations of adiposity with LTL.
biological aging; Northern Finland Birth Cohorts; telomere length; vitamin D
Abbreviations: BMI, body mass index; CRP, C-reactive protein; LTL, leukocyte telomere length; MET, metabolic equivalent of task;
NFBC1996, Northern Finland Birth Cohort 1966; 25(OH)D, 25-hydroxyvitamin D; qPCR, quantitative real-time polymerase chain
reaction; SEP, socioeconomic position.
In addition to a well-established role in bone metabolism,
the active form of vitamin D (calcitriol) is purported to have a
range of biological effects in many types of nonskeletal tissue
and cells (1). Epidemiologic studies have found associations
of higher vitamin D status, as measured by circulating 25-
hydroxyvitamin D (25(OH)D) concentration, with a lower
risk of all-cause mortality and several nonskeletal diseases,
including cardiovascular disease and cancer (2–4), albeit
with many equivocal and uncertain ﬁndings (5). Evidence
from randomized controlled trials is currently insufﬁcient for
drawing conclusions on causality for most disease outcomes
(6), but trial evidence does suggest that small-dose vitamin
D supplementation may lead to lower all-cause mortality
risk (6). These ﬁndings are supported by evidence from a
Mendelian randomization analysis of potential causal effects
of 25(OH)D on mortality (7). Thus, if vitamin D status is
causally related to mortality risk, it may be exerting effects
via 1 or more biological pathways, including the maintenance
of telomere length.
Telomeres are nucleoprotein “caps” formed of repetitive
DNA sequences and specialized proteins at the ends of chro-
mosomes (8). They protect chromosomes from deterioration
and fusion during mitosis (9). Telomeres are progressively
erodedwith successive rounds of cell division and byattrition,
attributed to processes such as oxidative stress (10). There is
variation in telomere length between persons of equal chron-
ological age, due to differences in both genetic factors and
environmental determinants (including adiposity) (11–14).
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Shorter age-adjusted leukocyte telomere length (LTL), a stan-
dard measure of individuals’ telomeres, is associated with a
range of chronic conditions, including cardiovascular disease
(15) and type 2 diabetes (16). Shorter telomeres are also as-
sociated with an increased risk of several cancers, including
bladder cancer and gastric cancer (17), although longer LTL
is associated with increased risk of melanoma and some other
cancers (18). Despite the complex relationship between telo-
mere length and cancer risk, LTL is positively associated with
life span and inversely associated with several age-related
disorders, largely reﬂecting the associations observed for
25(OH)D (19).
Vitamin D status could plausibly affect the maintenance of
telomere length directly or via effects on inﬂuencing mecha-
nisms, such as inﬂammation and/or the rate of cell prolifera-
tion (20–23). If higher vitamin D status rate-limits telomere
attrition, 25(OH)D concentration could represent amodiﬁable
target for improving maintenance of telomere length over the
life course. Two large cross-sectional studies have examined
25(OH)D concentration in relation to LTL in samples of
healthy females (both pre- and postmenopausal) (24, 25).
Both found that higher 25(OH)D was associated with longer
LTL. However, to our knowledge, no study has yet presented
ﬁndings from a large population sample of both males and
females. It is also unclear whether such an association is pres-
ent in samples of younger adults, since the previous studies
had participants with mean ages of approximately 49 and
59 years.
In this study, we used data collected at 31 years of age on
5,096 male and female participants from Northern Finland
Birth Cohort 1966 (NFBC1966), with the following aims:
1) to search for cross-sectional associations of 25(OH)D
with LTL; 2) to assess whether the inverse cross-sectional
association of body mass index (BMI) with LTL previous-
ly reported in this cohort was independent of individual
25(OH)D concentrations (26); and 3) to test whether any ob-
served associations of 25(OH)D and BMI with LTL were in-
dependent of concentrations of C-reactive protein (CRP), a
marker of low-grade inﬂammation (hypotheses are illustrated
in Figure 1).
METHODS
Participants
The NFBC1966 is a prospective birth cohort study that
aimed to recruit all pregnant women living in the provinces of
Oulu and Lapland in northern Finland with expected delivery
Vitamin D Status Telomere Length Nonskeletal HealthOutcomes 
Adiposity
Low-Grade
Inflammation
Vitamin D Status
Telomere LengthAdiposity
A)
B)
Nonskeletal Health
Outcomes 
Low-Grade
Inflammation
Figure 1. Directed acyclic graphs illustrating the 2 main hypotheses being tested in 5,096 participants from Northern Finland Birth Cohort 1966,
1966–1997. The hypothesized directions of causality are represented by dashed arrows, and established causal links are shown by solid arrows.
A) A scenario in which higher 25-hydroxyvitamin D (25(OH)D) status is regarded as a potential determinant of longer leukocyte telomere length
(LTL), which in turn may affect risk of health outcomes. Adiposity would be regarded as a confounder of an association between 25(OH)D and
LTL, given that adiposity is a known determinant of 25(OH)D concentrations and a potential determinant of LTL (independent of effects on
25(OH)D). Inflammation may mediate an association between 25(OH)D and LTL, based on evidence that vitamin D may have antiinflammatory
effects and that low-grade inflammation may shorten LTL over time. (Other mechanisms by which vitamin D could affect health outcomes, besides
potential effects on LTL, were not investigated here, nor were we investigating associations of LTL with health outcomes.) B) A scenario in which
higher adiposity is regarded as a determinant of shorter LTL, in turn leading to effects on health outcomes. In this model, an association of adiposity
with LTL may be mediated by effects of adiposity on 25(OH)D concentrations and/or inflammation, or via other mechanisms (direct arrow from
adiposity to LTL).
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dates in 1966 (27). A total of 12,058 liveborn offspring, all of
white European ethnic origin, were enrolled in the cohort.
Detailed information was collected on them and their parents,
starting prenatally and with further follow-up thereafter. In
1997, all living offspring (at age 31 years) with known ad-
dresses were contacted and sent a postal questionnaire. A
subset of 8,463 offspring residing in the area of Oulu, Lap-
land, or Helsinki were also invited to undergo a clinical
assessment, which included blood sampling. Of these partic-
ipants, 6,033 attended the assessment. Informed written con-
sent for the use of the data was obtained, and approval was
granted by the Ethics Committee of the Northern Ostroboth-
nia Hospital District in Oulu, Finland, in accordance with the
Declaration of Helsinki. For this study, a total of 5,096 par-
ticipants had valid measures of 25(OH)D, LTL, and all covar-
iates of interest; these persons formed our study sample (see
Figure 2).
Measures
25(OH)D concentration. Blood samples drawn at the
31-year follow-up assessment in 1997 were collected in the
morning (between 8:00 AM and 11:00 AM) following an over-
night fast by participants. Samples were stored at−70°C until
analyzed. In 2008, frozen samples were thawed, and con-
centrations of 25-hydroxyvitamin D2 (25(OH)D2) and 25-
hydroxyvitamin D3 (25(OH)D3) were measured in 4 batches
using high-performance liquid chromatography–tandem
mass spectrometry. Total 25(OH)D concentration was de-
rived from the sum of 25(OH)D2 and 25(OH)D3 concentra-
tions. Further assay details are provided in the Web Appen-
dix, available at http://aje.oxfordjournals.org/.
Leukocyte telomere length. Mean relative LTL was mea-
sured in genomic DNA samples prepared from peripheral
blood leukocytes in 31-year assessment samples, using a
multiplex quantitative real-time polymerase chain reaction
(qPCR) method (28), with modiﬁcations as described previ-
ously (29). Brieﬂy, the multiplex qPCR method is based on a
measure of the ampliﬁcation of the telomeric DNA sequence
(T) relative to that of a single-copy gene (S) in each test sam-
ple, and normalized using a common reference DNA sample.
This provides “T/S ratios” for each DNA sample, which are
used as mean relative LTL values for participants. The overall
mean coefﬁcient of variation for T/S values of duplicate test
samples on the same plate was 5%, and the mean interrun co-
efﬁcient for selected samples was 6.2%.
Covariates. The following variables were regarded as
potential confounders of associations of 25(OH)D and BMI
with LTL: age, sex, BMI (in 25(OH)D-LTL models), socio-
economic position (SEP), diet quality, smoking, alcohol
consumption, physical activity, and oral contraceptive use
(women only) (12–14, 30–37). CRPwas investigated as a po-
tential mediator of associations.
Height and weight were measured at the assessment or de-
rived from self-reported questionnaire responses (0.6% of the
sample). BMIwas calculated asweight (kg) divided by height
squared (m2).
Information on SEP, diet, smoking, alcohol intake, physi-
cal activity, and type of contraceptive used (women only) was
recorded fromresponses to thepostal questionnaire sent aspart
of the 31-year follow-up. SEP was deﬁned from responses to
questions on occupation and employment status, with the fol-
lowing categories used: unskilled worker, skilled worker,
professional, farmer, or other (retired, student, or long-term
unemployed). A 6-category diet quality variable was calcu-
lated (ranging from healthiest quality (0) to unhealthiest qual-
ity (5)) based on reported frequency of intake of the following
food groups in the previous 6 months: grains, dairy foods,
vegetables, fruits, meat, ﬁsh, and eggs, and several miscella-
neous food types (38). Alcohol consumption was calculated
as a continuous variable (ethanol intake in g/day) from de-
tailed questions on type, strength, and frequency of alcoholic
drinks consumed. Physical activity level (metabolic equiva-
lent of task (MET)-hours/week) was calculated from in-depth
questions on the frequency of various forms of light and
strenuous activities undertaken (39). Smoking status was de-
rived from several questions: ever/never smoking, current
number of cigarettes per day for current smokers (continuous
scale), and current use or nonuse of alternative tobacco prod-
ucts (cigars, pipes, snuff, and chewing tobacco).Three variables
for these responses were entered as covariates into models to
capture a higher degree of information on smoking habits. A
binary variable was derived for whether or not female par-
ticipants used oral contraceptives, which interfere with vitamin
D metabolism and may also alter inﬂammatory processes (and
hence could affect LTL) (32, 40).
Serum high-sensitivity CRP concentrations were deter-
mined by means of an immunoenzymometric assay (Medix
Biochemica, Espoo, Finland). The intra- and interassay co-
efﬁcients of variation were 4.2% and 5.2%, respectively.
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Figure 2. Derivation of the analysis sample from Northern Finland
Birth Cohort 1966 (NFBC1966), 1966–1997. LTL, leukocyte telomere
length; 25(OH)D, 25-hydroxyvitamin D.
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Statistics
To account for seasonal variability, we adjusted 25(OH)D
levels for season of sampling by modeling values against their
dates of sampling with trigonometric sine and cosine functions
(see Web Appendix for more information). We used multi-
variable linear regression models to examine associations of
25(OH)D and BMI with LTL and to adjust for potential con-
founding and mediating factors. Natural logarithmic transfor-
mation was applied to telomere T/S ratio to obtain a normal
distribution of this variable as the outcome variable in regression
models. A random-effects term (calculated by maximum likeli-
hood estimation)was included in all models to account for batch
effects from LTL assay plates. Regression coefﬁcients and 95%
conﬁdence intervals were expressed in terms of relative percent
change in LTL per 1-nmol/L increase in 25(OH)D concentra-
tion or per unit increase in BMI, by reformatting ratios of geo-
metric means and 95% conﬁdence intervals into percentages.
We ﬁtted several multivariable models for examining each
exposure-outcome association. For examination of 25(OH)D-
LTL associations, model 1 included adjustment for exact age at
assessment (in days), sex, and 25(OH)D sampling batch. In
model 2, we included additional adjustments for potential con-
founders: BMI, SEP, diet quality, physical activity, smoking
status, alcohol consumption, and use of oral contraceptives. In
model 3, we also adjusted for CRP. To examine BMI-LTL asso-
ciations, model 1 included adjustment for age and sex only.
Model 2 also included adjustment for SEP, physical activity,
diet, smoking status, alcohol intake, and use of oral contracep-
tives. Adjustments for 25(OH)D and 25(OH)D sampling batch
were additionally added in model 3. Model 4 included adjust-
ment forCRP in addition to the adjustments included inmodel 3.
Given the possibility of sex-speciﬁc associations of
25(OH)D and BMI with LTL and associations that the use
of oral contraceptives could have with both 25(OH)D and
LTL (perhaps via modiﬁcation of inﬂammation exposure,
Table 1. Characteristics of Participants Included in Analyses and of Those Excluded Because of Missing Data on 1
or More Variables, Northern Finland Birth Cohort 1966, 1966–1997
Characteristic
Included (n = 5,096) Excluded (n≤ 937)
P Valuea
Median (IQR) % Median (IQR) %
Total 25(OH)D level, nmol/Lb 50.6 (14.9) 49.8 (15.3) 0.21
Age, yearsb 31.1 (0.35) 31.1 (0.34) 0.12
Female sex 51.8 53.7 0.27
Body mass indexc 24.0 (21.9–25.6) 24.1 (21.9–26.9) 0.32
Socioeconomic position 0.58
Farmer 3.6 3.5
Professional 23.8 23.3
Skilled worker 31 29.8
Unskilled worker 25.6 25.3
Other 15.8 18.1
Physical activity, MET-hours/week 11.3 (3.8–20.3) 10.5 (3.8–22.5) 0.72
Diet qualityd 0.41
0 7.5 7.1
1 24.3 25.8
2 30.4 27.9
3 26.6 25.9
4 or 5 11.3 13.3
Ever smoking, yes/no 63.2 64.1 0.64
Current smoking (n = 1,838), cigarettes/day 10 (5–20) 12 (7–20) 0.28
Use of alternative types of tobaccoe 3.4 4.1 0.31
Alcohol consumption, g/day 4.2 (1.1–11) 3.6 (0.9–8.7) 0.002
Use of oral contraceptives (women only) 23.6 21.3 0.26
C-reactive protein level, mg/L 0.75 (0.36–1.87) 0.78 (0.38–2.14) 0.17
Leukocyte telomere length, T/S ratio 1.13 (0.91–1.41) 1.16 (0.95–1.46) 0.03
Abbreviations: IQR, interquartile range; MET, metabolic equivalent of task; 25(OH)D, 25-hydroxyvitamin D.
a P for differencebetween excluded and includedparticipants, based ona2-tailed t test, Kruskall-Wallis test, or χ2 test.
b Values are presented as mean (standard deviation) because of the variable’s approximately normal distribution.
c Weight (kg)/height (m)2.
d Lower values indicate a healthier diet.
e Cigars, pipes, snuff, or chewing tobacco.
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for example) within females, we tested for interactions with sex
in 25(OH)D-LTL analyses and BMI-LTL analyses, as well as
interactions with oral contraceptive use (women only).
We tested for possible nonlinearity of associations be-
tween exposures and outcomes by examining fractional poly-
nomial statistics and graphical plots. To evaluate whether
there were more pronounced differences in LTL among per-
sons with large differences in 25(OH)D concentrations, we
ﬁtted multivariable regression models comparing mean
LTL in persons with 25(OH)D levels under 50 nmol/L and
between 50 nmol/L and 75 nmol/L with mean LTL in those
with 25(OH)D levels over 75 nmol/L. We also repeated
25(OH)D analyses without adjusting 25(OH)D for season
of sampling, in order to obtain results more comparable to
those of a previous cross-sectional study of relevance to
our hypotheses that did not apply seasonal adjustment (25).
In case there were inaccuracies in the qPCR measurement of
extreme LTL values, we repeated the main analyses with
LTL-value outliers excluded (≥3 standard deviations from
the mean of the loge-transformed T/S ratio distribution).
RESULTS
Table 1 shows characteristics of NFBC1966 participants in
the analysis sample, along with corresponding information
on those excluded because of missing data. In general these
groups were comparable; there was evidence that persons in
the analysis sample had higher alcohol consumption and
lower LTL than those excluded, but numerical differences for
these characteristics were small, and the groups did not differ
on average in any other respect. Mean 25(OH)D concentra-
tion in the analysis sample (50.6 nmol/L) was similar to pre-
viously reported mean concentrations in a comparable study
sample from southern Finland (47 nmol/L and 45 nmol/L
in women and men, respectively; probably lower because
25(OH)D was measured at the seasonal nadir of 25(OH)D
concentration in late winter/early spring) (41).
Web Table 1 shows the characteristics of NFBC1966 par-
ticipants across the 25(OH)D distribution. There were in-
creasing trends in physical activity, diet quality, alternative
tobacco use, and use of oral contraceptives by women across
increasing ﬁfths of 25(OH)D concentration. There was also
an approximately linear decreasing trend in BMI across in-
creasing ﬁfths, and SEP category patterning varied across
the 25(OH)D distribution. No trends were observed for age,
sex, cigarette smoking variables, CRP, or LTL.
Table 2 shows results from multivariable regression mod-
els of associations of 25(OH)D with LTL. There was no ev-
idence for an association in model 1, where results were
adjusted only for age and sex. Results were essentially un-
changed after further adjustments for potential confounders
and mediators in models 2 and 3.
Multivariable associations of BMI with LTL are shown in
Table 3. BMI was inversely associated with LTL in model 1,
adjusted for age and sex. The strength of association was al-
most identical with further adjustment for SEP, diet, physical
activity, smoking status, and alcohol consumption (model 2)
and additional adjustment for 25(OH)D (model 3). The asso-
ciation was attenuated slightly with additional adjustment for
CRP, but it remained strong (model 4).
There was no evidence for an interaction between 25(OH)D
and BMI in associations with LTL (P = 0.55). There was also
no evidence for interactions in the association of either expo-
sure with LTL by sex or oral contraceptive use in the subsam-
ple of females only (all P’s ≥ 0.39). There was no evidence
that the associations examined deviated from linearity (all
fractional polynomial P’s ≥ 0.36).
Web Table 2 shows results from models comparing mean
LTLs by category of 25(OH)D concentration. Consistent
with ﬁndings from linear models, there was no evidence
of differences in LTL in lower categories of 25(OH)D
(<50 nmol/L or 50–75 nmol/L) compared with the highest
category (>75 nmol/L).
Models using 25(OH)D without adjustment for season of
sampling did not differ notably from themain results shown in
Table 2 (data available upon request). Exclusion of extreme
values from the LTL distribution (≥3 standard deviations)
Table 2. Associations of 25-Hydroxyvitamin D With Leukocyte
Telomere Length in Adults Aged 31 Years (n = 5,096) From Northern
Finland Birth Cohort 1966, 1966–1997
Mean Difference in LTL, %a 95% CI P Value
Model 1b −0.01 −0.2, 0.2 0.94
Model 2c −0.01 −0.2, 0.2 0.91
Model 3d −4 × 10−5 −0.2, 0.2 0.97
Abbreviations: CI, confidence interval; LTL, leukocyte telomere
length; 25(OH)D, 25-hydroxyvitamin D.
a Relative percent change in LTL (T/S ratio) per 1-nmol/L increase
in 25(OH)D.
b Results were adjusted for age, sex, and 25(OH)D batch.
c Results were adjusted for the factors in model 1 plus body mass
index, socioeconomic position, physical activity, diet, smoking status,
alcohol intake, and use of oral contraceptives (women only).
d Results were adjusted for the factors in model 2 plus C-reactive
protein.
Table 3. Associations of Body Mass Indexa With Leukocyte
Telomere Length in Adults Aged 31 Years (n = 5,096) From Northern
Finland Birth Cohort 1966, 1966–1997
Mean Difference in LTL, %b 95% CI P Value
Model 1c −0.4 −0.6, −0.2 0.001
Model 2d −0.4 −0.6, −0.2 0.001
Model 3e −0.4 −0.6, −0.2 <0.001
Model 4f −0.3 −0.6, −0.1 0.01
Abbreviations: CI, confidence interval; LTL, leukocyte telomere
length; 25(OH)D, 25-hydroxyvitamin D.
a Weight (kg)/height (m)2.
b Relative percent change in LTL (T/S ratio) per unit increase in
body mass index.
c Results were adjusted for age and sex.
d Results were adjusted for the factors in model 1 plus socioecono-
mic position, physical activity, diet, smoking status, and alcohol intake.
e Results were adjusted for the factors in model 2 plus 25(OH)D
and 25(OH)D batch.
f Results were adjusted for the factors in model 3 plus C-reactive
protein.
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produced no differences in the results of the main models
(data available upon request).
DISCUSSION
The ﬁndings of this study do not support the hypothesis
that higher circulating 25(OH)D concentrations are associ-
ated with longer LTL in young adults. Moreover, we have
shown that the previously reported inverse association of
BMI and LTL in these data is independent of individuals’
25(OH)D status and partly independent of low-grade chronic
inﬂammation. Our ﬁnding that the BMI-LTL association was
attenuated slightly with adjustment for CRP supports the pos-
sibility that 1 or more aspects of inﬂammation partly mediate
any causal effects of adiposity on the maintenance of telo-
mere length, which is consistent with past ﬁndings (42).
The lack of an association of 25(OH)D with LTL in this
study contrasts with ﬁndings from 2 previous cross-sectional
studies. In a study of 2,160 female twins in the United King-
dom (mean age = 49.4 (standard deviation, 12.9) years),
25(OH)Dwas positively associatedwithLTLafter adjustment
for age, season of 25(OH)D sampling, menopausal status, use
of hormone replacement therapy, physical activity, and the
twins’ family structure (24). Several other potential con-
founders (BMI, smoking, and circulating insulin and CRP
concentrations) were not included as adjustments following
a Bayesian model selection. In a study of 1,337 female regis-
tered nurses in the United States (mean age = approximately
59 years), Liu et al. (25) also reported a positive association
of 25(OH)D with LTL after adjustment for age, smoking sta-
tus, BMI, and physical activity. It is not obvious why our
ﬁndings differ from these. Unlike those analyses, this study’s
sample included men and women, but there were no differ-
ences in associations of 25(OH)D with LTL by sex (i.e.,
null ﬁndings for both), and the large size of our sample
meant that we would have had adequate power to detect a
magnitude of association similar to that reported previously
from data on women alone. Many of the characteristics were
similar between samples, such as participants being exclu-
sively or predominantly of white European ethnicity. It is
possible that we did not observe an association of 25(OH)D
with LTL in this study because its sample was of a notably
younger average age (mean age = 31 years). Associations of
25(OH)D with cardiovascular disease risk factors are less
pronounced in younger samples than in comparable older
samples (43, 44). Given the high variability in LTL between
individuals from birth onwards (45), it is unlikely that varia-
tion in LTL was too limited by age 31 years in our sample for
detecting an association with 25(OH)D concentrations.
Rather, if the previous results were not chance ﬁndings (24,
25), it may be that a 25(OH)D-LTL association emerges later
in the life course than young adulthood, and our ﬁndings do
not preclude the possibility (or conﬁrm) that such an associ-
ation would be observable in our study sample at older ages.
We have extended a previous analysis of the cross-
sectional associations of adiposity measures with LTL within
this cohort by examining potential mediation of the BMI-
LTL association by 25(OH)D and CRP (26). The association
of BMI with LTL in these data is consistent with some, but
not all, studies that have examined this issue to date (46). The
disparate ﬁndings may have arisen from the wide diversity of
characteristics within and between different study samples
used (26). The fact that the association of BMI with LTL
was attenuated somewhat but remained following adjustment
for CRP suggests that inﬂammation could, at least in part, me-
diate any effects that higher adiposity may have on increased
telomere degradation, if this association represents a causal re-
lationship (wewere unable to infer causality between adiposity
and LTL in this study). However, CRP measurement provides
information on only 1 aspect of a multitude of inﬂammatory
pathways that may link LTL with adiposity. It would therefore
be of interest to examine the impact of adjustment for a wider
set of inﬂammatory markers and adipokines on BMI-LTL as-
sociations observed in future epidemiologic studies.
Strengths and limitations
This study used the largest sample to date for examining
associations of 25(OH)D with LTL. To our knowledge, it is
also the ﬁrst to have used a nonselected population sample of
both men and women.
The main limitation of this study was its cross-sectional
design. At present, we lack data that would allow for longitu-
dinal analyses with LTL measured later in the life course.
With only a single 25(OH)D measurement for participants,
this may not have accurately captured long-term variation in
vitamin D exposure, which could have introduced regression
dilution bias (i.e., any true associations with outcomes would
have been biased toward the null). However, 25(OH)D mea-
sures have been shown to correlate over several years (47), and
our use of a single measurement is consistent with previous
studies reporting associations of 25(OH)Dwith LTL (24, 25).
Conclusions
Despite the lack of association of 25(OH)Dwith LTL among
young adults in this study, it is possible that an association
could becomemore pronouncedwith variation in 25(OH)D ex-
posure over further decades of life, into middle and old age.
This would explain disparities between this study and previous
ﬁndings from samples of older women (24, 25). Given the im-
plications of telomere length as an independent risk factor for
chronic disease and the scope of the modiﬁability of 25(OH)D
concentrations in populations (particularly those at northerly lat-
itudes) (48), more studies of associations between 25(OH)D and
LTLarewarranted. Ideally, these studieswoulduse aprospective
designwithmeasuresofLTLat several timepoints across the life
course, to assess potential associations with the rate of telomere
shortening. The use of 25(OH)D-determining genetic variants
in Mendelian randomization analyses could also help investiga-
tors to assess whether there is a long-term causal role for vitamin
D status in the maintenance of telomere length (49, 50). Several
variants suitable for this purpose have been identiﬁed for
25(OH)D and used in Mendelian randomization analyses to as-
sess the relationship of vitamin D to other outcomes (51, 52).
The increasing availability of LTL data on participants in
large cohort studies could make this approach feasible in the
future. Prospective and genetic epidemiology studies withmore
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data on LTL and inﬂammatory markers will also help to eluci-
date the role(s) that adiposity and inﬂammation may play in the
maintenance of telomere length, and the possible down-
stream consequences for chronic disease and mortality risk.
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